1. Home
  2. DVA vs AVY Comparison

DVA vs AVY Comparison

Compare DVA & AVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • AVY
  • Stock Information
  • Founded
  • DVA 1994
  • AVY 1935
  • Country
  • DVA United States
  • AVY United States
  • Employees
  • DVA N/A
  • AVY N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • AVY Containers/Packaging
  • Sector
  • DVA Health Care
  • AVY Consumer Discretionary
  • Exchange
  • DVA Nasdaq
  • AVY Nasdaq
  • Market Cap
  • DVA 12.6B
  • AVY 15.4B
  • IPO Year
  • DVA 1995
  • AVY N/A
  • Fundamental
  • Price
  • DVA $173.05
  • AVY $193.36
  • Analyst Decision
  • DVA Hold
  • AVY Buy
  • Analyst Count
  • DVA 5
  • AVY 12
  • Target Price
  • DVA $153.40
  • AVY $233.63
  • AVG Volume (30 Days)
  • DVA 533.7K
  • AVY 588.6K
  • Earning Date
  • DVA 02-11-2025
  • AVY 01-30-2025
  • Dividend Yield
  • DVA N/A
  • AVY 1.82%
  • EPS Growth
  • DVA 41.03
  • AVY 40.44
  • EPS
  • DVA 9.24
  • AVY 8.33
  • Revenue
  • DVA $12,666,614,000.00
  • AVY $8,680,500,000.00
  • Revenue This Year
  • DVA $6.18
  • AVY $5.89
  • Revenue Next Year
  • DVA $3.58
  • AVY $4.56
  • P/E Ratio
  • DVA $18.74
  • AVY $23.51
  • Revenue Growth
  • DVA 6.34
  • AVY 4.84
  • 52 Week Low
  • DVA $107.44
  • AVY $181.99
  • 52 Week High
  • DVA $178.75
  • AVY $233.48
  • Technical
  • Relative Strength Index (RSI)
  • DVA 70.13
  • AVY 53.03
  • Support Level
  • DVA $167.57
  • AVY $189.61
  • Resistance Level
  • DVA $170.80
  • AVY $193.97
  • Average True Range (ATR)
  • DVA 3.66
  • AVY 3.26
  • MACD
  • DVA 1.75
  • AVY 1.16
  • Stochastic Oscillator
  • DVA 79.39
  • AVY 74.55

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.

About AVY Avery Dennison Corporation

Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification, or RFID, inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.

Share on Social Networks: